The sky might be the limit for a biotech company with a pipeline candidate that beat the world's top-selling drug in a ...
Analyst Jason McCarthy from Maxim Group reiterated a Buy rating on Gain Therapeutics (GANX – Research Report) and keeping the price ...
BETHESDA, Md., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the ...
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 9.81% of ...
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, ...
Data support the ability of GT-02287 to prevent several steps in the disease cascade resulting from GCase misfolding and dysfunctionBETHESDA, Md., March 05, 2024 (GLOBE NEWSWIRE) ...
Leap Therapeutics Inc (LPTX) stock saw a modest uptick, ending the day at $3.01 which represents a slight increase of $0.27 or 9.85% from the prior close of $2.74. The stock opened at $2.85 and ...
Foghorn Therapeutics Inc. (FHTX) shares rallied 9.5% in the last trading session to close at $9.72. This move can be attributable to notable volume with a higher number of shares being traded than in ...
Viking Therapeutics, Inc. (VKTX) ended the recent trading session at $67.10, demonstrating a +0.55% swing from the preceding day's closing price. The stock exceeded the S&P 500, which registered a ...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $49.49, moving -0.2% from the previous trading session. This change lagged the S&P 500's 1.7% gain on the day. Elsewhere, the Dow ...